A message for our patients from our Acting CEO

13 June 2025

Dear patients and families,

We are devastated about the recent incidents at our Brisbane and Clayton clinics, and the anxiety this may be causing our patients.

I want to reassure you that Monash IVF is committed to providing the highest standards of care and we want to be transparent with you about how we're responding to the incidents at our Clayton and Brisbane laboratories:

• We have immediately implemented interim additional verification processes and patient confirmation safeguards, over and above normal practice and in addition to our electronic witnessing systems. These new safeguards are designed to strengthen confidence in both digital and manual settings by ensuring an added layer of confirmation and witnessing.
• We have expanded the scope of the independent review, led by Fiona McLeod AO SC, which was originally established following the incident at our Brisbane clinic. While the circumstances of the Clayton and Brisbane events are different, we believe both must be examined thoroughly to ensure we learn everything we can and implement any necessary changes.
  
  

Monash IVF has extended its sincere apologies to the affected patients, and we continue to support them.

I know that your care and treatment are the absolute priorities for our scientists and doctors, and I want to assure you that the continuity of your treatment is not affected by these incidents.

Michael Knaap has made the decision to step down as CEO and Managing Director. We thank him for his years of dedicated service.

I have been appointed Acting CEO and my clear focus is on patient care and safety. If you have any questions or concerns, please contact our dedicated Monash IVF support team on 1300 139 438.

All of us at Monash IVF know the responsibility we have in the work that we do. We will do everything we can to strengthen how we do things so we can continue to support people in their dreams of building a family.

We are here to support you.

Kind regards,
Malik Jainudeen
(Acting Chief Executive Officer)